Velázquez A, Terán M, Báez A, Gutiérrez J, Rodríguez R
Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas UNAM, México.
Am J Clin Nutr. 1995 Feb;61(2):385-91. doi: 10.1093/ajcn/61.2.385.
We studied the effect of a supplement of biotin (10 mg/d) or a placebo under double-blind conditions on plasma biotin concentrations and lymphocyte propionyl CoA carboxylase (PCC) and pyruvate carboxylase (PC) in 22 children with severe protein-energy malnutrition (PEM) (5 with kwashiorkor, 10 with marasmus, and 7 "sugar babies"). There were significant differences between the malnourished and control subjects only for PCC, although not among the three PEM types. Six of the patients had both PC and PCC activities below the lowest of the normal control subjects; there was no correlation between biotin concentrations and carboxylase activities in individual patients. In response to biotin supplementation, the greatest change in lymphocyte carboxylase activities was detected in patients who had abnormally decreased initial carboxylase activities, but the response was not related to initial plasma biotin concentration. These results indicate that these enzyme deficiencies are the result of a nutritionally determined biotin deficiency, that carboxylases and especially PCC are better indicators of the biotin status in individual patients than is the plasma biotin concentration, and that in some malnourished patients biotin deficiency may be rate-limiting in their nutritional homeostasis.
我们在双盲条件下研究了补充生物素(10毫克/天)或安慰剂对22名重度蛋白质-能量营养不良(PEM)儿童(5名夸希奥科病患儿、10名消瘦症患儿和7名“糖宝宝”)血浆生物素浓度以及淋巴细胞丙酰辅酶A羧化酶(PCC)和丙酮酸羧化酶(PC)的影响。尽管三种PEM类型之间没有差异,但营养不良受试者与对照受试者之间仅在PCC方面存在显著差异。6名患者的PC和PCC活性均低于正常对照受试者的最低值;个体患者的生物素浓度与羧化酶活性之间没有相关性。在补充生物素后,初始羧化酶活性异常降低的患者中淋巴细胞羧化酶活性变化最大,但该反应与初始血浆生物素浓度无关。这些结果表明,这些酶缺乏是营养性生物素缺乏的结果,羧化酶尤其是PCC比血浆生物素浓度更能反映个体患者的生物素状态,并且在一些营养不良患者中,生物素缺乏可能是其营养稳态的限速因素。